Capmatinib hydrochloride
| Capmatinib hydrochloride | |
|---|---|
| Term | Capmatinib hydrochloride |
| Short definition | Capmatinib hydrochloride - (pronounced) (kap-MA-tih-nib HY-droh-KLOR-ide) A drug used to treat adults with non-small cell lung cancer that has spread and has a specific mutation (change). METGen. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Capmatinib hydrochloride - (pronounced) (kap-MA-tih-nib HY-droh-KLOR-ide) A drug used to treat adults with non-small cell lung cancer that has spread and has a specific mutation (change). METGen. It is also being studied in the treatment of other types of cancer. Capmatinib hydrochloride blocks a protein made by theMETGene that can help stop cancer cells from growing and kill them. It's a type of tyrosine kinase inhibitor. Also called Tabrecta
External links
- Medical encyclopedia article on Capmatinib hydrochloride
- Wikipedia's article - Capmatinib hydrochloride
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski